logo
Select company
Select metric
-390.44%Operating Cash Flow Margin
VS
Market
7
Sector
25
Industry
45
History
70
$ 4.41Close
$ 2.88 - $ 4.9 52-Week Range
Ticker Information

Ticker

ABUS

Company Name

ARBUTUS BIOPHARMA CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ARBUTUS BIOPHARMA CORP - Operating Cash Flow Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ABUS - OCF % Historical data
DateNet Cash Flow - OperationsOperating Cash Flow MarginRevenues
6/30/2025$ -60.19M-390.44%$ 15.42M
3/31/2025$ -58.95M-920.6%$ 6.4M
12/31/2024$ -64.85M-1050.88%$ 6.17M
9/30/2024$ -71.83M-1065.37%$ 6.74M
6/30/2024$ -72.88M-724.33%$ 10.06M
3/31/2024$ -77.93M-600.11%$ 12.99M
12/31/2023$ -85.94M-473.71%$ 18.14M
9/30/2023$ -85.63M-385.03%$ 22.24M
6/30/2023$ -82.54M-350.72%$ 23.54M
3/31/2023$ -83.28M-251.4%$ 33.13M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ARBUTUS BIOPHARMA CORP's latest trailing twelve months (TTM) OCF % stands at -809.94%.
  • Over the past 5 years, ARBUTUS BIOPHARMA CORP's average OCF % has been -542.98%.
  • The median OCF % for ARBUTUS BIOPHARMA CORP during this period was -607.35%
  • ARBUTUS BIOPHARMA CORP reached its highest OCF % over the past 5 years at -90.61%.
  • The lowest OCF % recorded by ARBUTUS BIOPHARMA CORP in the same timeframe -1065.37%

ARBUTUS BIOPHARMA CORP's OCF % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

OCF % Benchmarks
CompanyOCF %
ZBIO : ZENAS BIOPHARMA INC -989.38%QURE : UNIQURE NV -1209.72%NUVB : NUVATION BIO INC -1171.66%VIR : VIR BIOTECHNOLOGY INC -2407.63%BCYC : BICYCLE THERAPEUTICS PLC -1080.77%IMNM : IMMUNOME INC -1419.36%RLAY : RELAY THERAPEUTICS INC -3128.55%CAPR : CAPRICOR THERAPEUTICS INC -395.71%ALMS : ALUMIS INC -1721.45%TSHA : TAYSHA GENE THERAPIES INC -1014.14%

Definition of Operating Cash Flow Margin

[Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
CF - Operations / Revenues
(=) OCF %
OCF % for ARBUTUS BIOPHARMA CORP is calculated as follows: CF - Operations [ $ -49.78M ] / Revenues [ $ 6.15M ]
(=) OCF % [ -809.94% ]

ABUS - Operating Cash Flow Margin, Last 5 years

-1065.37%

Minimum

Sep 30, 2024

-90.61%

Maximum

Dec 31, 2022

-542.98%

Average

-607.35%

Median

OCF % Benchmark Analysis

The chart above depicts the distribution of OCF % for companies in the Total Stock Market. The average OCF % of the companies is 14.31% with a standard deviation of 21.13%.
The following table provides additional summary stats:
OCF % in the Market:
filtered constituents3.25K
min-57.27%
max77.08%
average14.31%
median12.65%
std21.13%